Respiratory syncytial virus: how, why and what to do.

@article{Rodrguez2014RespiratorySV,
  title={Respiratory syncytial virus: how, why and what to do.},
  author={Rosa Rodr{\'i}guez and Octavio Ramilo},
  journal={The Journal of infection},
  year={2014},
  volume={68 Suppl 1},
  pages={S115-8}
}
Bronchiolitis is the leading cause of hospitalization of infants and young children worldwide. Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in infants. Studies conducted using molecular diagnostic assays confirmed that RSV accounts for over 50% of bronchiolitis in young children requiring hospitalization. Those studies demonstrate that it is common to identify RSV in association with a second viral agent but it is yet unclear whether the simultaneous detection of… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Palivizumab a humanized monoclonal antibody directed against the F protein of RSV is the only agent licensed to prevent severe RSV disease in high - risk children .
Palivizumab a humanized monoclonal antibody directed against the F protein of RSV is the only agent licensed to prevent severe RSV disease in high - risk children .
All Topics